Maureen Sanderson1, Heather O'Hara2, Nia Foderingham2, William D Dupont3, Xiao-Ou Shu3, Neeraja Peterson3, Alecia M Fair3, Anthony C Disher4. 1. Department of Family and Community Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd, Nashville, TN, 37208, USA. msanderson@mmc.edu. 2. Department of Family and Community Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd, Nashville, TN, 37208, USA. 3. Vanderbilt University Medical Center, Nashville, TN, 37203, USA. 4. Department of Radiology, Meharry Medical College, Nashville, USA.
Abstract
PURPOSE: We conducted a study of women recruited at Meharry Medical College, a historically black medical school, to investigate the relationship between diabetes and mammographic breast density. METHODS: A total of 476 women completed in-person interviews, body measurements, and full-field digital mammograms on a Hologic mammography unit from December 2011 to February 2014. Average percent breast density for the left and right breasts combined was estimated using Quantra, an automated algorithm for volumetric assessment of breast tissue. The prevalence of type 2 diabetes was determined by self-report. RESULTS: After adjustment for confounding variables, the mean percent breast density among premenopausal women with type 2 diabetes [[Formula: see text] 13.8 %, 95 % confidence interval (CI) 11.6-15.9] was nonsignificantly lower than that of women without type 2 diabetes ([Formula: see text] 15.9 %, 95 % CI 15.0-16.8) (p = 0.07); however, there was no association among postmenopausal women. The effect of type 2 diabetes in severely obese women (BMI ≥ 35) appeared to differ by menopausal status with a reduction in mean percent breast density in premenopausal women, but an increase in mean percent breast density in postmenopausal women which could have been due to chance. CONCLUSIONS: Confirmation of our findings in larger studies may assist in clarifying the role of the insulin signaling breast cancer pathway in women with high breast density.
PURPOSE: We conducted a study of women recruited at Meharry Medical College, a historically black medical school, to investigate the relationship between diabetes and mammographic breast density. METHODS: A total of 476 women completed in-person interviews, body measurements, and full-field digital mammograms on a Hologic mammography unit from December 2011 to February 2014. Average percent breast density for the left and right breasts combined was estimated using Quantra, an automated algorithm for volumetric assessment of breast tissue. The prevalence of type 2 diabetes was determined by self-report. RESULTS: After adjustment for confounding variables, the mean percent breast density among premenopausal women with type 2 diabetes [[Formula: see text] 13.8 %, 95 % confidence interval (CI) 11.6-15.9] was nonsignificantly lower than that of women without type 2 diabetes ([Formula: see text] 15.9 %, 95 % CI 15.0-16.8) (p = 0.07); however, there was no association among postmenopausal women. The effect of type 2 diabetes in severely obesewomen (BMI ≥ 35) appeared to differ by menopausal status with a reduction in mean percent breast density in premenopausal women, but an increase in mean percent breast density in postmenopausal women which could have been due to chance. CONCLUSIONS: Confirmation of our findings in larger studies may assist in clarifying the role of the insulin signaling breast cancer pathway in women with high breast density.
Authors: Marcela G del Carmen; Kevin S Hughes; Elkan Halpern; Elizabeth Rafferty; Daniel Kopans; Yuri R Parisky; Armando Sardi; Lisa Esserman; Steven Rust; James Michaelson Journal: Cancer Date: 2003-08-01 Impact factor: 6.860
Authors: Karin B Michels; Caren G Solomon; Frank B Hu; Bernard A Rosner; Susan E Hankinson; Graham A Colditz; JoAnn E Manson Journal: Diabetes Care Date: 2003-06 Impact factor: 19.112
Authors: Zhengjia Chen; Anna H Wu; W James Gauderman; Leslie Bernstein; Huiyan Ma; Malcolm C Pike; Giske Ursin Journal: Am J Epidemiol Date: 2004-01-15 Impact factor: 4.897
Authors: Marilyn A Roubidoux; Judith Salmon Kaur; Kent A Griffith; Jeff Sloan; Charlton Wilson; Paul Novotny; Michael Lobell Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-06 Impact factor: 4.254
Authors: Jeff Wang; Ania Azziz; Bo Fan; Serghei Malkov; Catherine Klifa; David Newitt; Silaja Yitta; Nola Hylton; Karla Kerlikowske; John A Shepherd Journal: PLoS One Date: 2013-12-04 Impact factor: 3.240
Authors: Karsten Buschard; Katrin Thomassen; Elsebeth Lynge; Ilse Vejborg; Anne Tjønneland; My von Euler-Chelpin; Zorana Jovanovic Andersen Journal: Cancer Causes Control Date: 2016-11-10 Impact factor: 2.506
Authors: Erica J Lee Argov; Teofilia Acheampong; Mary Beth Terry; Carmen B Rodriguez; Mariangela Agovino; Ying Wei; Shweta Athilat; Parisa Tehranifar Journal: Breast Cancer Res Date: 2020-09-15 Impact factor: 6.466